Plasma Fractionation Market: Global Industry Analysis and Forecast (2022-2029)

Global Plasma Fractionation Market was valued at US$ 27 Bn. in 2021. Global Plasma Fractionation Market size is expected to grow at a CAGR of 6.89 % through the forecast period.
Global Plasma Fractionation Market Overview:
Plasma fractionation is the post-processing step after donor-obtained plasma. Blood's fluid component, plasma, is fractionated to produce various plasma derivatives, including albumin and immunoglobulins. These plasma-derived compounds are used to treat a variety of blood plasma-related diseases and have therapeutic effects.



To know about the Research Methodology   :- Request Free Sample Report

Immunoglobulins can help cure autoimmune disorders and boost the immune system. Blood disorders like haemophilia are treated with clotting factors, and albumins are helpful when albumin levels are low or when there has been fluid loss.

The report explores the Plasma Fractionation Market's segments (Connectivity and Content, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2020. The report investigates the Plasma Fractionation Market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Plasma Fractionation Market's contemporary competitive scenario
Plasma Fractionation Market Dynamics:
The main driver of the plasma fractionation market's growth is the rise in the number of elderly people around the world, who are more likely to have rare diseases that call for the usage of plasma derivatives.

Utilization of plasma-derived immunoglobulins in numerous therapeutic indications, such as autoimmune and inflammatory illnesses, is rising. The increased use of immunoglobulins and alpha-1-antitrypsin in various branches of medicine around the world also contributes to the market's expansion for plasma fractionation.

Increased lung-infecting respiratory illnesses are present in the COVID-19 scenario. Diabetes and high blood pressure are problems for some patients, and family history often has a big impact. Therefore, plasma fractionation is often used to treat the condition.

Another significant element that boosts the market's expansion is the increase of plasma collection facilities around the world. The government's positive support for raising public knowledge about the use of plasma-derived goods also contributes to the market's expansion.
Plasma Fractionation Market Segment Analysis:
Based on the product type plasma fractionation market is segmented into Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other.

The plasma fractionation market for immunoglobulin is the largest and is anticipated to increase at the fastest rate over the prediction period. The usage of immunoglobulins in a variety of conditions, including autoimmune diseases, inflammatory diseases, and primary and secondary immunological deficiencies, has contributed to the expansion of this market. Another factor driving the expansion of the immunoglobulin market is the spike in immunology-related research taking place all over the world.



Based on the application plasma fractionation market is segmented into Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology and Others. Immunology has the largest market share owing to the factors such as increasing usage of plasma proteins in the treatment of immune deficiencies.

Based on the processing technology plasma fractionation market is segmented into Ion- Exchange Chromatography , Affinity Chromatography, Cryopreservation, Ultrafiltration and Microfiltration. Ion- exchange chromatography has the largest market share owing to the factor such as the high purification capability using ions by removing inorganic substances.

Based on the end user plasma fractionation market is segmented into Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others. Hospitals & clinics has the largest market share due to improving infrastructure and health care facilities provided by hospitals, along with increasing off- label use of plasma fractionated products in hospitals to treat various diseases..
Plasma Fractionation Market Regional Insights:
The market for plasma fractionation in North America is dominated by the region with the highest CAGR in the global plasma fractionation market because residents there are more aware of the broad benefits of plasma and because the prevalence of respiratory disorders is on the rise. Additionally, the existence of important players, an increase in plasma collection facilities, an increase in immunoglobulin consumption, and the capacity to supply plasma due to the viability of plasma collection & distribution all contribute to the regional market's growth.

Asia-Pacific is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of the Asia-Pacific market are the rising consumption of plasma-derived products, the strategic developments made by the companies in this region, the presence of leading players, and contract fractionation agreements between the countries.

Europe is also the dominating market due to the geriatric population and immune deficiency diseases.
Plasma Fractionation Market Scope: Inquire before buying



Global Plasma Fractionation Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2029


Historical Data:
2017 to 2021
Market Size in 2021:
US$ 27 Bn.


Forecast Period 2022 to 2029 CAGR:
6.89%
Market Size in 2029:
US$ 46 Bn.


 Segments Covered:
by Type
• Immunoglobulins
• Coagulation Factor Concentrates
• Albumin
• Protease Inhibitors
• Other


by Application
• Immunology
• Hematology
• Neurology
• Critical Care
• Hemato-Oncology
• Rheumatology
• Others


by processing technology
• Ion- Exchange Chromatography
• Affinity Chromatography
• Cryopreservation
• Ultrafiltration
• Microfiltration


by End-User
• Hospitals & Clinics
• Clinical Research Laboratories
• Academic Institutions
• Others



Plasma Fractionation Market by Region
• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa
Plasma Fractionation Market Key Players
• Bio Products Laboratory
• Biotest AG
• China Biologic Products Holdings Inc.
• CSL Limited
• Green Cross Corporation
• Grifols
• Japan Blood Products Organization
• Kedrion
• LFB group
• Octapharma AG
• Sanquin Blood Supply Foundation
• Takeda Pharmaceutical Company Limited.
• Baxter
• Green Cross Corporation
• Shanghai RAAS
• Bharat Serums and Vaccines Limited
• Merck KGaA
• ADMA Biologics
• Boccard
• Intas Pharmaceuticals Ltd.

Frequently Asked Questions:

1] What segments are covered in the Global Plasma Fractionation Market report?
Ans. The segments covered in the Plasma Fractionation Market report are based on product Type, Application, processing technology and end user.

2] Which region is expected to hold the highest share in the Global Plasma Fractionation Market?
Ans. North America region is expected to hold the highest share in the Plasma Fractionation Market.

3] What is the market size of the Global Plasma Fractionation Market by 2029?
Ans. The market size of the Plasma Fractionation Market by 2029 is expected to reach US$ 46 Bn.

4] What is the forecast period for the Global Plasma Fractionation Market?
Ans. The forecast period for the Plasma Fractionation Market is 2021-2029.

5] What was the market size of the Global Plasma Fractionation Market in 2021?
Ans. The market size of the Plasma Fractionation Market in 2021 was valued at US$ 46 Bn.